FDA Inspection 1100373 — Amarin Pharma Inc.
The FDA completed an inspection of Amarin Pharma Inc. on August 2, 2019 in Bedminster, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bedminster, NJ (United States)
Additional Details
Sponsor, Contract Research Organization